MANAGING the CARE of HEALTH and the CURE of DISEASE Part II: Integration
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Evolving Ideas About Business Strategy
Pankaj Ghemawat Evolving Ideas about Business Strategy This paper updates an earlier article published in Business History Review that concluded that by the second half of the 1990s, there had been a profusion of new, purportedly practical ideas about strategy, many of which embodied some explicit dynamics. This update provides several indications of a drop- off since then in the rate of development of new ideas about strategy but also a continued focus, in the new ideas that are being developed, on dynamics. And since our stock of dynamic frameworks has, based on one enumeration, more than doubled in the last fifteen to twenty years, updating expands both the need and the empirical basis for some gener- alizations about the types of dynamic strategy frameworks— and strategy frameworks in general—that managers are likely to find helpful versus those that they are not. n 2002, I published an article in the Business History Review, “Com- Ipetition and Business Strategy in Historical Perspective,” that at- tempted to provide an overview of the evolution of practical—rather than academic—ideas about business strategy from the beginnings of the field through the second half of the 1990s. It concluded that, by then, (1) there had been a profusion of new ideas about strategy, which had probably started in the early to mid-1980s, and (2) many of the new ideas embodied some explicit dynamics, compared with the typical- ly timeless or static approaches to strategy that had previously domi- nated the field. The article was, however, qualified in its -
Extending the Cure: Policy Responses to the Growing Threat Of
RAMANAN LAXMINARAYAN and ANUP MALANI with David Howard and David L. Smith EXTENDING THE CURE Policy responses to the growing threat of antibiotic resistance EXTENDING THE CURE RAMANAN LAXMINARAYAN and ANUP MALANI with David Howard and David L. Smith EXTENDING THE CURE Policy responses to the growing threat of antibiotic resistance © Resources for the Future 2007. All rights reserved. LIBRARY OF CONGRESS CATALOGING-IN-PUBLICATION DATA Laxminarayan, Ramanan. Extending the cure : policy responses to the growing threat of antibiotic resistance / by Ramanan Laxminarayan and Anup Malani ; with David Howard and David L. Smith. p. ; cm. Includes bibliographical references. ISBN 978-1-933115-57-3 (pbk. : alk. Paper) 1. Drug resistance in microorganisms—United States. 2. Drug resistance in microorganisms—Government policy—United States. I. Malani, Anup. II. Title. III. Title: Policy responses to the growing threat of antibiotic resistance. [DNLM: 1. Drug Resistance, Bacterial—United States. 2. Anti-Bacterial Agents—United States. 3. Drug Utilization—United States. 4. Health Policy—United States. QW 52 L425e 2007] QR177.L39 2007 616.9`041—dc22 2007008949 RESOURCES FOR THE FUTURE 1616 P Street, NW Washington, DC 20036-1400 USA www.rff.org ABOUT RESOURCES FOR THE FUTURE RFF is a nonprofit and nonpartisan organization that conducts independent research—rooted primarily in economics and other social sciences—on environmental, energy, natural resources, and public health issues. RFF is headquartered in Washington, D.C., but its research scope comprises programs in nations around the world. Founded in 1952, RFF pioneered the application of economics as a tool to develop more effective policy for the use and conservation of natural resources. -
MANAGING the CARE of HEALTH and '11:11; CURE of DISEASE Part I: Differentiation
MANAGING THE CARE OF HEALTH AND '11:11; CURE OF DISEASE Part I: Differentiation by S. GLOUBERMAN and H. MINTZBERG 98/49/SM * Faculty of Medicine, University of Toronto, Sunnybrook Health Sciences Centre, Baycrest Centre for Geriatric Care, Toronto, Canada, and King Edward's Hospital Fund, London. ** Faculty of Management, McGill University, 1001 Sherbrooke St. W., Montreal Quebec H3A 1G5 and Professor of Organisation at INSEAD, Boulevard de Constance, 77305 Fontainebleau Cedex, France. A working paper in the INSEAD Working Paper Series is intended as a means whereby a faculty researcher's thoughts and findings may be communicated to interested readers. The paper should be considered preliminary in nature and may require revision. Printed at INSEAD, Fontainebleau, France. Managing the Care of Health and the Cure of Disease Part I: Differentiation by Sholom Glouberman and Henry Mintzberg Sholom Glouberman Henry Mintzberg Faculty of Medicine, Faculty of Management, University of Toronto, McGill University Sunnybrook Health 1001 Sherbrooke St. W. Sciences Centre Montreal, Quebec H3A 1 G5 and Baycrest Centre for Geriatric Care, Toronto January 1996 4/. This paper is based on a variety of small research interventions, including observation of a range of health care managers, from the chief executive of the National Health Service in England to practicing clinical directors, and a series of seminars conducted with the support of the King Edward's Hospital Fund for London. Our deep appreciation goes to the many thoughtful people in the English system, including those of the King's Fund College, who participated in these experiences. 1 Why are the so-called systems of health care so notoriously difficult to manage? No country appears to be satisfied with the current state of its system; almost everywhere reforms are being contemplated, organized, or implemented, some in direct contradiction to others. -
The Illusive Strategy ...25 Years Later
THE ILLUSIVE STRATEGY ...25 YEARS LATER by Henry Mintzberg Published in 1993 in Arthur Bedeian Management Laureates: A Collection of Autobiographical Essays (JAI Press, Volume I) Courtesy of Elsevier Science (http://www.elsevier.com). This document may be used for personal research. Admonitions I was going to close this piece with the advice to the young scholar that you should always take your work seriously but never yourself. I put it here instead to express my apprehensions in doing this. I think it is useful to have on record comments on how careers that were lucky enough to emerge successfully unfolded, but there is the danger that the person in question will be taken, and will take him or herself, too seriously. To have succeeded in studying something or other has never made anyone intrinsically interesting; indeed I find some of my successful colleagues terrible bores. In line with this, I try here to avoid discussing my private life. That is my own business; the issue in question is my working life. But because the two are obviously intertwined, I would like to make a single comment here about them. When I wrote on the back cover of Mintzberg on Management: Inside Our Strange World of Organizations (1989a1) that it "is written for those of us who spend our public lives dealing with organizations and our private lives escaping from them," I was not joking. That, if anything, has characterized much of my behavior. I am intrigued by organizations; all my work has set out to understand them. But when I play, I distance myself from them as far as possible. -
Medications Used for Behavioral and Emotional Disorders: a Guide for Parents, Foster Parents
MEDICATIONS USED FOR BEHAVIORAL & EMOTIONAL DISORDERS A GUIDE FOR PARENTS, FOSTER PARENTS, FAMILIES, YOUTH, CAREGIVERS, GUARDIANS, AND SOCIAL WORKERS Final May 10, 2010 Overview This booklet is a guide for parents and other caregivers to help you understand the medications that are sometimes used to help children with behavioral or emotional problems. Being able to talk openly with your child’s doctor or other health care provider is very important. This guide may make it easier for you to talk with your child's doctors about medications. You will find information about the medications that may be used to help treat these conditions in children. How these medications work and possible side effects are also included. As a parent or caregiver of a child with a behavioral or emotional disorder, you may be feeling overwhelmed as you try to help your child cope with his or her problems. Many parents and caregivers feel that nobody understands the frustration of caring for a child with a behavioral or emotional disorder. But many other families are in the same situation. According to one study, over 4 million children ages 9 to 17 have some kind of emotional or behavioral problem that affects their daily lives. 2 Getting Help Children with behavioral or emotional disorders are a special group and need special care. Many times children have symptoms that are different from adults with the same disorder. Symptoms may also vary from child to child, and it can be difficult to understand a child's signs and symptoms. Children may have trouble understanding their illness and may not be able to describe how they feel. -
Definition of Cure for Hodgkin's Disease
[CANCER RESEARCH 31, 1828-1833, November 1971] Definition of Cure for Hodgkin's Disease Emil Frei, III, and Edmund A. Gehan The Department of Developmental Therapeutics [E. M.] and the Department of Biomathematics [E. A. G./, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, Houston, Texas 77025 Summary whose progressive death rate from all causes is similar to that of a normal population of the same sex and age constitution." "We can speak of cure for Hodgkin's disease when in I would add that it should also be unassociated with time-probably a decade or so after treatment-there remains a continuing morbidity from the disease or its treatment. While group of disease-free survivors whose progressive death rate this excellent definition is quite acceptable for Hodgkin's from all causes is similar to that of a normal population of the disease (or for most cancers, for that matter), it has the major same age and sex constitution." Analysis of survival curves for limitation that it takes years to determine the cure rate of a patients with Hodgkin's disease indicates that even for patients given form of treatment. The rapid progress in therapeutic with Stage I and II disease there is excessive mortality per unit research has brought focus on the need for determining the time as compared to the control population for at least 10 probability of cure as early as possible. years after treatment. Thus, while the above definition is acceptable, the lag period required for the evaluation of Survival Data for Selected Other Cancers potentially curative treatment is very long. -
Henry Mintzberg Résumé (August 2017)
Henry Mintzberg résumé (August 2017) I have been an academic most of my working life. After receiving my undergraduate degree in Mechanical Engineering from McGill University in Montreal (1961), I worked in Operational Research at the Canadian National Railways, and then received a masters and doctorate from the MIT Sloan School of Management in Boston. In 1968 I returned to McGill, where I joined what is now the Desautels Faculty of Management, where I am Cleghorn Professor of Management Studies, having been half-time since the mid 1980s. (I have also spent the equivalent of about 6 years of my life in France.) I devote myself largely to writing and research, over the years especially about managerial work, strategy formation, and forms of organizing. I have published about 180 articles and 19 books including Managers not MBAs (2004), Tracking Strategies (2007), Simply Managing (2013), and in 2015 Rebalancing Society, the implications of which are now my central focus. Managing the Myths of Health Care came out in 2017. (If you are interested in how I research and write, please see Developing Theory about the Development of Theory.) In recent years, I have done more general writing, including commentaries and a regular TWOG (TWeet2blOG: @mintzberg141 to mintzberg.org/blog), as “provocative fun in a page or 2 beyond pithy pronouncements in a line or 2.” A collection of these will be published under the title Managing with Soul: Farwell to leadership at the “top”, Here comes managing on the ground. I have worked for much of the past two decades, in collaboration with colleagues around the world, on developing new approaches to management education and development. -
Managing Chronic Conditions. Experience in Eight Countries
European on Health Systems and Policies MANAGING CHRonIC CONDITIONS Experience in eight countries Ellen Nolte, Cécile Knai, Martin McKee Observatory Studies Series No 15 Managing chronic conditions The European Observatory on Health Systems and Policies supports and promotes evidence- based health policy-making through comprehensive and rigorous analysis of health systems in Europe. It brings together a wide range of policy-makers, academics and practitioners to analyse trends in health reform, drawing on experience from across Europe to illuminate policy issues. The European Observatory on Health Systems and Policies is a partnership between the World Health Organization Regional Office for Europe, the Governments of Belgium, Finland, Norway, Slovenia, Spain and Sweden, the Veneto Region of Italy, the European Investment Bank, the Open Society Institute, the World Bank, the London School of Economics and Political Science and the London School of Hygiene & Tropical Medicine. Managing chronic conditions Experience in eight countries Ellen Nolte Cécile Knai Martin McKee Keywords: CHRONIC DISEASE - prevention and control DISEASE MANAGEMENT DELIVERY OF HEALTH CARE - organization and administration DENMARK FRANCE GERMANY THE NETHERLANDS SWEDEN UNITED KINGDOM AUSTRALIA CANADA EUROPE © World Health Organization 2008, on behalf of the European Observatory on Health Systems and Policies All rights reserved. The European Observatory on Health Systems and Policies welcomes requests for permission to reproduce or translate its publications, in part or in full. Address requests about publications to: Publications, WHO Regional Office for Europe, Scherfigsvej 8 DK-2100 Copenhagen Ø, Denmark Alternatively, complete an online request form for documentation, health information, or for permission to quote or translate, on the Regional Office web site (http://www.euro.who.int/pubrequest). -
How the Current System Fails People with Chronic Illnesses
How the Current System Fails People With Chronic Illnesses Reinhard Priester Robert L. Kane Annette M. Totten Copyright 2005 by the Society of Actuaries. All rights reserved by the Society of Actuaries. Permission is granted to make brief excerpts for a published review. Permission is also granted to make limited numbers of copies of items in this monograph for personal, internal, classroom or other instructional use, on condition that the foregoing copyright notice is used so as to give reasonable notice of the Society's copyright. This consent for free limited copying without prior consent of the Society does not extend to making copies for general distribution, for advertising or promotional purposes, for inclusion in new collective works or for resale. 1 Abstract The Institute of Medicine concluded in 2001 that with regard to quality, “between the health care we have and the care we could have lies not just a gap, but a chasm.” In fact, the chasm is not only over quality. The lack of access, financial barriers, high costs and workforce shortages are among the other dimensions of our health care system that further expose the chasm between “what is” and “what should be.” These deficiencies are particularly troubling for people with chronic conditions who, on average, use the health care system more frequently, consume more health care resources and are more likely to see multiple health care professionals and have long- term relationships with them. When the health care system fails, chronically ill patients are often harmed the most. The foremost reason America’s health care system cannot optimally provide the services needed by people with chronic conditions is that the system remains based on an episodic, acute care medical model. -
Mintzberg Cycles of Org Change
Cycles of Organizational Change Author(s): Henry Mintzberg and Frances Westley Source: Strategic Management Journal, Vol. 13, Special Issue: Fundamental Themes in Strategy Process Research (Winter, 1992), pp. 39-59 Published by: John Wiley & Sons Stable URL: http://www.jstor.org/stable/2486365 . Accessed: 12/08/2011 04:11 Your use of the JSTOR archive indicates your acceptance of the Terms & Conditions of Use, available at . http://www.jstor.org/page/info/about/policies/terms.jsp JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range of content in a trusted digital archive. We use information technology and tools to increase productivity and facilitate new forms of scholarship. For more information about JSTOR, please contact [email protected]. John Wiley & Sons is collaborating with JSTOR to digitize, preserve and extend access to Strategic Management Journal. http://www.jstor.org Strategic Management Journal, Vol. 13, 39-59 (1992) CYCLESOF ORGANIZATIONALCHANGE HENRYMINTZBERG and FRANCESWESTLEY Faculty of Management, McGill University, Montreal, Quebec, Canada Much of the theory and research about change in organizations, by being presented free of rich context, creates a certain amount of confusion in the literature. This paper seeks to help remedy that situation by developing a comprehensive framework of change by organizations, built on various cycles: concentric to represent the contents and levels of change, circumferential to represent the means and processes of change, tangential to represent the episodes and stages of change, and spiraling to represent the sequences and patterns of change. This framework is fleshed out in conclusion by developing three models of change experienced by major world religions, labeled enclaving, cloning, and uprooting. -
A Guided Tourthrough the Wilds of Strategic Management
A GUIDED TOURTHROUGH THE WILDS OF STRATEGIC MANAGEMENT HENRY MINTZBERG BRUCE AHLSTRAND JOSEPH LAMPEL THE FREE PRESS NEW YORK I &A", 4&d< There are some people who begin the Zoo at the beginning, called WAMN, and walk as quickly as they can past every cage until they come to the one called WAYOUT,but the nicest people go straight to the animal they love the most, and stay there. -A. A. Milne, in the Introduction to Winnie-The-Pooh THE FREE PRESS A Division of Simon & Schuster Inc. We dedicate this book to such people who are more interested in open 1230 Avenue of the Americas fields than closed cages. New York, NY 10020 Copyright O 1998 by Henry Mintzberg, Ltd., Bruce Ahlstrand, and Joseph Lampel All rights reserved, including the right of reproduction in whole or in part in any form. THE FREE PRESS and colophon are trademarks of Simon & Schuster Inc. Designed by Carla Bolte Manufactured in the United States of America 10987654 Permissions acknowledgments appear on pages 393-395. Library of Congress Cataloging-in-Publication Data Mintzberg, Henry. Strategy safari : a guided tour through the w~ldsof strateg~c management I Henry Mmtzberg, Bruce Ahlstrand, Joseph Lampel. p. cm. Includes bibl~ographicalreferences and ~ndex. 1. Strateg~cplannmg. L Ahlstrand, Bruce W. 11. Lampel, Joseph. Ill. Title. HD30.28.M564 1998 658.4'0124~21 98-9694 CIP ISBN 0484- 847434 (hardcover) .- r& ? "5d&s-&?r&&* CONTENTS Embarkation ..........................ix "And Over Here, Ladies and Gentlemen: The Strategic Management Beast" ............. .1 The Design School ..................... .23 Strategy Formation as a Process of Conception The Planning School .................. -
A Drug Is a Substance Intended for Use in the Diagnosis, Cure, Mitigation, Treatment, Or Prevention of Disease Or Other Conditions
Revenue Office 8101 Ralston Road Arvada, CO 80002 (720) 898-7100 - Phone (720) 898-7110 - Fax “Continuing to Build a Great Community” DRUGS A drug is a substance intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease or other conditions. Drugs are classified as substances obtainable only by physician directive (prescription and/or chart ordered drugs) or as "over the counter" preparations available to the general public (non-prescription drugs). TAXABLE DRUGS An "over the counter" drug is a medical substance which may be sold without a prescription and which is prepackaged for use by the consumer, properly labeled and is unadulterated ("in pure form") in accordance with the requirements of the Colorado Food and Drug Act (CRS 25-5-402) and the Federal Food, Drug, and Cosmetic Act (Title 21 U.S.C. 301 et seq., 52 Stat. 1040 et seq.). "Over the counter" drugs such as aspirin, pain relievers, cold capsules, cough syrups, anti-bacterial ointments, creams, petroleum jelly, etc., are taxable when purchased by individuals without a written prescription. TAX-EXEMPT DRUGS Prescription or Other Written Directive Prescription ordered drugs are exempt from sales and use taxes when the sale and purchase is for the direct personal use of a specific individual in accordance with a prescription or other written directive issued by a licensed practitioner of medicine, dentistry, or podiatry. A license to practice chiropractic does not grant the right to prescribe or administer drugs or to administer anesthetics - See CRS 12-33-118. A prescription order is defined as an order authorizing the dispensing of drugs by a licensed pharmacist according to written or other transmitted directive from a licensed practitioner and includes the name or identification of the patient, the date, and sufficient information for its preparation, dispensing and labeling.